| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |